Tenderwize
Back to tender search

Pharmaceutical procurement Amgros 2027

Amgros I/S·København Ø, Denmark·DKK 108M | EUR 14.4M·Deadline Aug 20, 2026 · 5 days left·Open·Supplies·Framework
High valueStructured notice only
Original notice title

Denmark – Pharmaceutical products – Amgros 2027 1.183.a

60/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

30 / 100

Risk factors

Structured data shows submission deadline 2026-08-20T22:00:00Z, but XML notice shows two different deadlines (2026-08-2...

No procurement documents were analyzed (only the notice). Key documents such as contract terms, specifications, and sub...

Submission deadline in 5 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • DKK 108M estimated value
  • Framework procurement
  • Supplies contract
  • 2 lots
  • Duration until Dec 2028
  • Supply of Glofitamab (ATC code L01FX28) in two strengths: 2.5 mg and 10 mg.
  • Delivery to hospital pharmacies in the Capital Region of Denmark (DK011).
Show full summary

This tender is a Danish public procurement for the supply of the pharmaceutical product Glofitamab in two strengths (2.5 mg and 10 mg) to hospital pharmacies, under non-exclusive framework agreements without purchase obligation. The award is based solely on price. The buyer is Amgros I/S, acting on behalf of the five Danish regions.

Risks

Structured data shows submission deadline 2026-08-20T22:00:00Z, but XML notice shows two different deadlines (2026-08-2...

No procurement documents were analyzed (only the notice). Key documents such as contract terms, specifications, and sub...

Submission deadline in 5 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Open procedure (unrestricted).
  • No minimum suitability requirements (no financial or other minimum criteria).
  • Variants not allowed.

Requirements may be incomplete.

Award Criteria

Lot 1

Price (100%)100%

Lot 2

Price (100%)100%

Buyer

Location

København Ø, DNK

Buyer profile

Open profile

Identifier

14479880

Activity

Health

Lots (2)

LOT-0001

Tender Number 1

Supply of Glofitamab 2.5 mg concentrate for infusion. Estimated quantity: 999 units at 1.429 mg per unit. Framework agreement for 2 years.

SuppliesFrameworkEU fundedElectronic submission

EUR 14.4M

Estimated value

Location

DK011, Denmark

Duration

Dec 2026 - Dec 2028

Category

Pharmaceutical products

Award Criteria

Price

Deadline

Deadline Aug 20, 2026

LOT-0002

Tender Number 2

Supply of Glofitamab 10 mg concentrate for infusion. Estimated quantity: 9,999 units at 1.429 mg per unit. Framework agreement for 2 years.

SuppliesFrameworkEU fundedElectronic submission

EUR 14.4M

Estimated value

Location

DK011, Denmark

Duration

Dec 2026 - Dec 2028

Category

Pharmaceutical products

Award Criteria

Price

Deadline

Deadline Aug 20, 2026

Procurement Details

Publication date
29 Jun 2026
Languages
Danish, Swedish

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
446076-2026

Documents (1)

Similar tenders